Next Article in Journal
First Generic Teriparatide: Structural and Biological Sameness to Its Reference Medicinal Product
Next Article in Special Issue
Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy
Previous Article in Journal
Delivery of DNA-Based Therapeutics for Treatment of Chronic Diseases
Previous Article in Special Issue
Acylation of Oleanolic Acid Oximes Effectively Improves Cytotoxic Activity in In Vitro Studies
 
 

Order Article Reprints

Journal: Pharmaceutics, 2024
Volume: 16
Number: 536

Article: A Novel Class of Human ADAM8 Inhibitory Antibodies for Treatment of Triple-Negative Breast Cancer
Authors: by Nora D. Mineva, Stefania Pianetti, Sonia G. Das, Srimathi Srinivasan, Nicolas M. Billiald and Gail E. Sonenshein
Link: https://www.mdpi.com/1999-4923/16/4/536

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop